These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20430057)
41. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase. Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950 [TBL] [Abstract][Full Text] [Related]
42. Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics. Nutho B; Meeprasert A; Chulapa M; Kungwan N; Rungrotmongkol T J Biomol Struct Dyn; 2017 Jun; 35(8):1743-1757. PubMed ID: 27236925 [TBL] [Abstract][Full Text] [Related]
43. Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation. Kitab B; Satoh M; Ohmori Y; Munakata T; Sudoh M; Kohara M; Tsukiyama-Kohara K J Biol Chem; 2019 Apr; 294(15):5759-5773. PubMed ID: 30755480 [TBL] [Abstract][Full Text] [Related]
44. RacGTPase-activating protein 1 interacts with hepatitis C virus polymerase NS5B to regulate viral replication. Wu MJ; Ke PY; Horng JT Biochem Biophys Res Commun; 2014 Nov; 454(1):19-24. PubMed ID: 25305482 [TBL] [Abstract][Full Text] [Related]
45. Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Beaulieu PL; Tsantrizos YS Curr Opin Investig Drugs; 2004 Aug; 5(8):838-50. PubMed ID: 15600240 [TBL] [Abstract][Full Text] [Related]
46. Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase. Howe AY; Bloom J; Baldick CJ; Benetatos CA; Cheng H; Christensen JS; Chunduru SK; Coburn GA; Feld B; Gopalsamy A; Gorczyca WP; Herrmann S; Johann S; Jiang X; Kimberland ML; Krisnamurthy G; Olson M; Orlowski M; Swanberg S; Thompson I; Thorn M; Del Vecchio A; Young DC; van Zeijl M; Ellingboe JW; Upeslacis J; Collett M; Mansour TS; O'Connell JF Antimicrob Agents Chemother; 2004 Dec; 48(12):4813-21. PubMed ID: 15561861 [TBL] [Abstract][Full Text] [Related]
47. A novel hepatitis C virus NS5B polymerase assay of de novo initiated RNA synthesis directed from a heteropolymeric RNA template. Ferrari E; Huang HC Methods Mol Biol; 2013; 1030():81-92. PubMed ID: 23821261 [TBL] [Abstract][Full Text] [Related]
48. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase. Wang YK; Rigat KL; Roberts SB; Gao M Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898 [TBL] [Abstract][Full Text] [Related]
49. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture. Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors. Ma H; Leveque V; De Witte A; Li W; Hendricks T; Clausen SM; Cammack N; Klumpp K Virology; 2005 Feb; 332(1):8-15. PubMed ID: 15661135 [TBL] [Abstract][Full Text] [Related]
51. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. Ferrari E; Wright-Minogue J; Fang JW; Baroudy BM; Lau JY; Hong Z J Virol; 1999 Feb; 73(2):1649-54. PubMed ID: 9882374 [TBL] [Abstract][Full Text] [Related]
53. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. Kim SJ; Kim JH; Kim YG; Lim HS; Oh JW J Biol Chem; 2004 Nov; 279(48):50031-41. PubMed ID: 15364941 [TBL] [Abstract][Full Text] [Related]
54. Resolution of the interaction mechanisms and characteristics of non-nucleoside inhibitors of hepatitis C virus polymerase. Winquist J; Abdurakhmanov E; Baraznenok V; Henderson I; Vrang L; Danielson UH Antiviral Res; 2013 Mar; 97(3):356-68. PubMed ID: 23305851 [TBL] [Abstract][Full Text] [Related]
55. The hepatitis C virus core protein can modulate RNA-dependent RNA synthesis by the 2a polymerase. Wen Y; Cheng Kao C Virus Res; 2014 Aug; 189():165-76. PubMed ID: 24874198 [TBL] [Abstract][Full Text] [Related]
56. Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B. Watashi K; Inoue D; Hijikata M; Goto K; Aly HH; Shimotohno K J Biol Chem; 2007 Nov; 282(45):32765-72. PubMed ID: 17704057 [TBL] [Abstract][Full Text] [Related]
57. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. Lee KJ; Choi J; Ou JH; Lai MM J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899 [TBL] [Abstract][Full Text] [Related]
58. Analysis of mutant NS5B proteins encoded by isolates from chimpanzees chronically infected following clonal HCV RNA inoculation. Lou H; Choi YH; LaVoy JE; Major ME; Hagedorn CH Virology; 2003 Dec; 317(1):65-72. PubMed ID: 14675625 [TBL] [Abstract][Full Text] [Related]
59. Biochemical properties of full-length hepatitis C virus RNA-dependent RNA polymerase expressed in insect cells. Choi HB; Kim YG; Oh JW Exp Mol Med; 2003 Dec; 35(6):475-85. PubMed ID: 14749524 [TBL] [Abstract][Full Text] [Related]
60. De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. Luo G; Hamatake RK; Mathis DM; Racela J; Rigat KL; Lemm J; Colonno RJ J Virol; 2000 Jan; 74(2):851-63. PubMed ID: 10623748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]